Company: IMNN
Filing Date: 2025-05-30
Form Type: 8-K
Source: 0001641172-25-013051
Chunk: 2

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: 8-K
Item: Item 3.01
Chunk 2
---
-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially
from those contained in such statements, including, without limitation, risks related to the Company’s ability to regain compliance
with Nasdaq’s continued listing requirements or otherwise maintain compliance with any other listing requirement of The Nasdaq
Capital Market, the potential delisting of the Company’s common stock from The Nasdaq Capital Market due to the Company’s
failure to comply with the applicable rules, the timing of the hearing and the Panel’s decision, which hearing may be scheduled,
and such decision may be issued, more quickly than expected, the outcome of the hearing and the Panel’s decision, and the other
risks set forth in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements contained
in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking
statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                    IMUNON,                                       
  Dated:            By:          /s/                              
                                 Susan                            
                                 General